When Baboon Dads Stick Around, Their Daughters Live Longer
The mammal world is sorely lacking in good dads —at least by human standards. In most mammalian species, males saddle the mother with their offspring while they continue to galavant around and sire more. That's how male baboons typically operate. But although these primate patriarchs don't nurse young or gather food (or provide any other essential care), a new study suggests their presence does have a beneficial impact.
In a paper published on Tuesday in Proceedings of the Royal Society B, researchers report that female baboons who have strong relationships with their father—as measured by the amount of time a father-daughter pair spent grooming each other and living together—tend to outlive those who don't. Of the 216 females in the study (all from Kenya's Amboseli ecosystem, where the Amboseli Baboon Research Project has been running since 1971), those with an engaged father enjoyed an extra two to four years of life.
This doesn't necessarily show that father-daughter bonding improves longevity; it may be that healthy young females, already destined for long lives, are more likely to bond with their father. But the paper's senior author Beth Archie, a behavioral ecologist at the University of Notre Dame, says her instinct is that baboon 'dads are more important than they seem at first glance.'
On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
One possible explanation for these results is that fathers create a 'zone of safety' around their daughters, intervening to protect them in conflicts. Alternatively, fathers may serve as a gateway to baboon society, allowing young females to establish connections that will benefit them for a lifetime. Whatever the baboon dads are doing, 'it does seem to make a difference,' says Robert Seyfarth, a primatologist and emeritus professor at the University of Pennsylvania, who was not involved in the study. The effect is probably similar for sons, Archie says, but they're harder to study because male baboons typically leave the group they were born into when they reach maturity. Researchers have tried to track their lifespan by putting radio collars on them, she adds, 'but the batteries died before the males did.'
Why are some baboon fathers more involved in their daughters' lives than others? The answer may be linked to the studied species' promiscuous practices: in the Amboseli population, both sexes have multiple mating partners, so paternity isn't always clear-cut. As expected, the researchers found that males spent more time grooming young females when they were confident they were in fact the father. (That's a call male baboons can realistically make: females' genitals swell and turn red during ovulation, so if a male mates with one and fends off competitors until that sign of fertility disappears, he can be reasonably sure that any resulting offspring is his.) In the study, the males also seemed to play a more active parenting role when mating opportunities trailed off. Once you're too old to compete with the swaggering young bucks for mates, Archie says, 'the best strategy is to invest more in your offspring.'
This 'dad mode,' as she calls it, is a powerful thing. Its significance in baboons resonates with our intuitions about the value of paternal care in our own species. Indeed, Archie thinks these findings from an evolutionary cousin may reveal something about the roots of human parenting. The big message, she says, is that 'having a strong relationship with your parents is important for leading a long, healthy life. That seems to be a primate universal.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
4 hours ago
- Newsweek
Psychopaths Share This Brain Trait, Scans Reveal
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Psychopaths have different brain structures to the rest of the population, a study has revealed, helping shed new light on one corner of the "dark personality" triad. Diagnosis with psychopathy is recognized as one of the strongest indicators of persistent violent behavior. Using advanced neuroimaging techniques and the publicly accessible Julich-Brain Atlas, researchers from institutions in Germany and the University of Pennsylvania have pinpointed brain networks that show structural alterations in people exhibiting psychopathic traits. The study represents an important step in understanding the neurobiological base of aggression and antisocial behavior. A man receives a brain scan. A man receives a brain scan. gorodenkoff/Getty Images In their study, the research team examined MRI data on 39 adult male participants diagnosed with psychopathy and compared them with a group of control subjects. The study's findings revealed a notable link between antisocial tendencies and specific brain structures. The researchers used a diagnostic tool called the Psychopathy Check-List and found that higher scores in the "lifestyle and antisocial behavior" category were associated with lower volumes in several brain areas. These lower volumes were found in widespread areas including the basal ganglia—which is involved in motor control and learning—and the thalamus, a "relay station" for sensory information. Reductions were also seen in parts of the brainstem; the cerebellum, which is important for motor control and coordination; and other areas like the orbitofrontal and insular regions—both of which are crucial for emotion regulation, decision-making and social behavior. This suggests that the parts of the brain involved in controlling behavior might not be working as well in people with psychopathy. In contrast, the associations with traits that cover "interpersonal-affective" aspects like pathological lying and a lack of empathy were found to be less consistent. Beyond these specific associations, group comparisons revealed a significant reduction in total brain volume in the psychopathy group compared to the control group. The most localized and pronounced difference was observed in the right subiculum, a part of the hippocampus known for its role in memory. This suggests "a rather widespread disturbance of brain development in psychopathic subjects," according to the study's conclusions. The authors' findings ultimately suggest "a particularly strong neurobiological link between antisocial behavior and reduced brain volume across widespread regions." Still, the researchers acknowledged certain limitations of the study, like the use of different MRI scanners across sites, which was accounted for statistically; and that not all groups were matched for cognitive capacity or substance use, which could influence comparisons. Ultimately, the study marks a large advancement in understanding the neurobiological factors linked to aggression. Future research could explore questions such as whether these structural differences may be inherited or influenced by environmental factors. Do you have a tip on a science story that Newsweek should be covering? Do you have a question about psychopathy? Let us know via science@ Reference Pieperhoff, P., Hofhansel, L., Schneider, F., Müller, J., Amunts, K., Weber-Papen, S., Weidler, C., Clemens, B., Raine, A., & Habel, U. (2025). Associations of brain structure with psychopathy. European Archives of Psychiatry and Clinical Neuroscience.


Gizmodo
a day ago
- Gizmodo
Notorious Fungus Blamed for ‘Mummy's Curse' Is Now a Promising Cancer Treatment
In the 1920s, a number of workers on the excavation team that uncovered King Tutankhamun's tomb met untimely deaths. Five decades later, 10 out of 12 scientists died after entering the tomb of the 15th-century Polish King Casimir IV. In both cases, researchers suggested that fungal spores could have played a role in the mysterious deaths, specifically identifying the fungus Aspergillus flavus within the Polish burial. A. flavus is now making a comeback, but not as a reawakened killer from ancient tombs, but instead as a surprisingly effective cancer-fighting compound. By modifying a newly identified molecule found in the fungus, the researchers created a compound that performed as effectively against leukemia cells as FDA-approved drugs. The molecules at the center of these anti-cancer properties, known as ribosomally synthesized and post-translationally modified peptides, or RiPPs, are a diverse group of natural molecules assembled by the ribosome (which makes proteins) and later modified by enzymes. They conduct many different biological activities, some of which are already known for their anti-cancer properties. To date, researchers have identified only a handful of RiPPs in fungi—which is significantly less than the thousands previously discovered in bacteria. Part of the problem is that scientists didn't fully understand how fungi create RiPPs. 'The synthesis of these compounds is complicated,' Qiuyue Nie, a postdoctoral fellow at the University of Pennsylvania's Department of Chemical and Biomolecular Engineering, said in a university statement. 'But that's also what gives them this remarkable bioactivity.' Genetic analysis suggested that a specific A. flavus protein could be a source of fungal RiPPs. Sure enough, when Nie and her colleagues turned off the genes responsible for said protein, RiPPs' chemical markers also vanished. Using this approach, the team discovered four different A. flavus RiPPs with a previously undocumented structure of interlocking rings. After researchers purified these RiPPs, which they named asperigimycins, two of the four unique molecules performed well against human leukemia cells without further modifications. When mixed with a lipid (a fatty molecule), a separate RiPPs variant performed as well as cytarabine and daunorubicin, both of which are long-established FDA-approved leukemia drugs. To investigate this lipid's enhancement properties, the researchers went back to turning genes off and on. In this way, they identified a gene associated with the process that lets enough asperigimycins into the cancer cells. 'This gene acts like a gateway,' said Nie, the first author of the study published Monday in Nature Chemical Biology. 'It doesn't just help asperigimycins get into cells, it may also enable other 'cyclic peptides' to do the same.' Cyclic peptides are other chemicals with known medicinal properties. 'Knowing that lipids can affect how this gene transports chemicals into cells gives us another tool for drug development,' Nie added. The researchers also discovered that asperigimycins might disrupt the process of cell division—which is good news for cancer treatment, since cancer consists of uncontrolled cell division. Furthermore, the compounds had little to no effect on breast, liver, or lung cancer cells, as well as on a number of bacteria and fungi. While this might sound like a negative thing, asperigimycins' potentially targeted impact would be an important characteristic for future medications. Moving forward, the researchers aim to test asperigimycins in animal trials. The recent study investigates a promising new cancer therapy, but it also paves the way for future research into fungal medicines. 'Nature has given us this incredible pharmacy,' said Sherry Gao, senior author of the study and an associate professor also in the University of Pennsylvania's Department of Chemical and Biomolecular Engineering. 'It's up to us to uncover its secrets.'
Yahoo
a day ago
- Yahoo
Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells
A potentially deadly fungus known as "pharaoh's curse fungus" could offer an unexpected path to fighting cancer, recent research shows. Scientists from the University of Pennsylvania modified molecules from the fungus — which is officially called Aspergillus flavus — to create a new compound and enhance its cancer-killing properties. "Fungi gave us penicillin," said Dr. Xue (Sherry) Gao, an associate professor at UPenn and leader of the study, in a press release. "These results show that many more medicines derived from natural products remain to be found." Single Dose Of 'Magic Mushrooms' Provides 5 Years Of Depression Relief, Researchers Find The findings were published in the journal Nature Chemical Biology. Aspergillus flavus is found in decaying leaves and compost, as well as on trees, plants and some crops, according to Mayo Clinic. Read On The Fox News App While the fungus doesn't endanger most healthy people, it can cause respiratory issues for those who have weakened immune systems or are taking certain medications. Some of the more severe complications of the fungus can include bleeding in the lungs and life-threatening infections in the brain, heart and kidneys, Mayo Clinic stated. After archaeologists opened King Tut's tomb in the 1920s, multiple members of the excavation team died suddenly, fueling rumors of a "curse" upon those who dared interfere with the pharaoh's rest, according to the UPenn press release. Decades later, doctors hypothesized that fungal spores, which had been dormant for thousands of years, could have infected the team. In the 1970s, it happened again, the university stated. A dozen scientists entered another tomb, this time in Poland — and 10 died within a few weeks. Later investigations were said to reveal the presence of Aspergillus flavus in the tomb. Now, the same fungus linked to King Tut's tomb could have the capability to fight leukemia in a new form of cancer therapy. "There are a variety of compounds able to be produced by fungus," Gao told Fox News Digital. These compounds can be toxic to different cells, she noted, depending on the "biological management we are able to mitigate." Cancer Could Be Detected Three Years Before Diagnosis With Experimental Blood Test The study aimed to find a specific kind of compound — ribosomally synthesized and post-translationally modified peptides, or "RiPPs" — within Aspergillus flavus, which was previously shown to be a good source. When this compound is able to enter cancer cells, Gao said, it may be able to stop their growth. "Cancer cells divide uncontrollably," Gao said in the release. "These compounds block the formation of microtubules, which are essential for cell division." When mixed with human cancer cells, two variants of the molecules within these RiPPS were found to have potent effects against leukemia cells, the researchers found. Another variant performed as well as two FDA-approved drugs that have been used for decades to treat leukemia (cytarabine and daunorubicin). Tiffany Troso-Sandoval, M.D., a medical oncologist and cancer care consultant based in New York, cautioned that this study, which was performed on cell cultures, is still in the very early stages. Your Favorite Alcoholic Beverage Could Be Linked To Deadly Form Of Cancer, Study Finds "It's still very far away from being applicable to use in humans with leukemia," Troso-Sandoval, who was not involved in the study, told Fox News Digital. Speaking about RiPPs, the doctor told Fox News Digital, "What they're referring to [in the study] is basically a rare type of bioactive molecule that they have isolated from this fungus." There are multiple subtypes of leukemia, Troso-Sandoval pointed out, including acute and chronic forms. "One treatment might not work on [another] type of leukemia," she noted. Further testing is needed to determine which subtypes may contain the active molecule. The compound explored in the study had little to no effect on breast, liver or lung cancer cells, the researchers noted. This suggests that its disruptive effects only work on certain types of cells, which will be an important consideration when developing medications. Click Here To Sign Up For Our Health Newsletter Looking ahead, the researchers plan to test the fungus' potential in animal models and, ultimately, human trials. Gao told Fox News Digital she is "excited about what nature can create and how it can benefit our society." For more Health articles, visit The study received support from the National Institutes of Health, the University of Pennsylvania, the Welch Foundation, the Houston Area Molecular Biophysics Program, the Cancer Prevention and Research Institute of Texas and the National Science article source: Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells